Guest Speaker
Prof. Isabelle Ray-Coquard MD PhD
President of the Gineco group
Centre Leon Bérard
Reshape lab. Inserm U1290
Université Claude Bernard Lyon Est
Lyon France
Dr. Isabelle Ray-Coquard is a Professor of Medicine in Medical Oncology at Université Claude Bernard Lyon I and a leading international expert in gynecologic cancers. She serves as President of the GINECO group and Director of the French National Network for Rare Ovarian Tumors. Her research spans clinical trials, rare cancer networks, and translational oncology, with a focus on ovarian and uterine cancers.
With over two decades of leadership in both academic and clinical research, Dr. Ray-Coquard has spearheaded numerous national and international trials, including PAOLA-1 and NeoPembrOv. She is widely published in top oncology journals and actively collaborates with organizations such as GCIG, ESMO, and ESGO, advancing care for women with rare and complex gynecologic malignancies.
Conference Chairs
Stephanie Lheureux MD PhD
Drug Development Program - Gynecology
Division of Medical Oncology & Hematology
Gynecology Site Lead
Princess Margaret Cancer Centre
Westaway Chair for Ovarian Cancer Research
Associate Professor, Institute of Medical Science
Temerty Faculty of Medicine, University of Toronto
Tiffany Zigras MD MSc FRCSC
Gynecologic Oncologist- Trillium Health Partners
Assistant Professor Department of Obstetrics & Gynaecology
Temerty Faculty of Medicine, University of Toronto
Regional Lead Cervical Screening and Colposcopy - Ontario Health
Scientific Planning Committee
Lisa Ould Gallagher RN
Dr. Miri Ratner Herskovitz
Dr. Anjelica Hodgson
Dr. Julia Skliarenko
Dr. Stephen Welch
Faculty Disclosure
It is the policy of the University of Toronto, Temerty Faculty of Medicine, Continuing Professional Development to ensure balance, independence, objectivity, and scientific rigor in all its individually accredited or jointly accredited educational programs.
Speakers and/or planning committee members, participating in University of Toronto accredited programs, are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains but is not limited to relationships within the last TWO (2) years with not-for-profit organizations, pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of facts.
It remains for the audience to determine whether the speaker’s outside interests may reflect a possible bias in either the exposition or the conclusions presented.